HLS Therapeutics (HLTRF) Q4 2024 Earnings

Nov 7Confirmed
Nov 2022
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.17
-0.15
-0.12

Details

Expected EPS
-0.124875
Actual EPS
-0.15
Surprise EPS
-0.03
Surprise Percent
-20.12%

Description

⁨HLS Therapeutics⁩ (⁦HLTRF⁩) has reported earnings of ⁦-0.15⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts